Nektar Therapeutics (NKTR) climbed 12.56% or 10.08 to $90.35. It is nearly 4.32 million shares traded, which is 167.14% compare to the average total volume 2.58 million. The market cap of NKTR is $15.49 billion. The year to date change is 39.24%. The 52 week price range is from $17.51 to $111.36. Price of NKTR have changed -0.38% during last week. It have changed -4.05% over last month, -7.27% over last 3 months, 48.68% over last 6 months N/A
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NKTR is 89.79. It is -0.62% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for NKTR is 60.67. It is -32.85% below current price. The 52-week High is 111.36. It is 23.25% from the current price. The 52-week Low is 17.51. It is -80.62% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of NKTR is 4.72 on 2018-05-15. Short % to float is 6.93%. There are some statistics of NKTR. It is has market cap $15.49 billion. The share outstanding is 171.40 million. The average volume is 2.58 million. The revenue is 187.52M. It has 618.11M cash and 495.35M in debt. The gross profit is 172.85M. The percent of top 15 Institution holding is 96.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NKTR is -233.71%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NKTR is -23.21%.